vs

Side-by-side financial comparison of AVIAT NETWORKS, INC. (AVNW) and MEDIFAST INC (MED). Click either name above to swap in a different company.

AVIAT NETWORKS, INC. is the larger business by last-quarter revenue ($111.5M vs $75.1M, roughly 1.5× MEDIFAST INC). On growth, AVIAT NETWORKS, INC. posted the faster year-over-year revenue change (-5.7% vs -36.9%). AVIAT NETWORKS, INC. produced more free cash flow last quarter ($22.5M vs $-6.6M). Over the past eight quarters, AVIAT NETWORKS, INC.'s revenue compounded faster (0.3% CAGR vs -34.4%).

Aviat Networks, Inc. is a global provider of microwave transport and backhaul solutions, providing public and private operators with communications infrastructure to serve telecommunications operators and enterprise customers.

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

AVNW vs MED — Head-to-Head

Bigger by revenue
AVNW
AVNW
1.5× larger
AVNW
$111.5M
$75.1M
MED
Growing faster (revenue YoY)
AVNW
AVNW
+31.2% gap
AVNW
-5.7%
-36.9%
MED
More free cash flow
AVNW
AVNW
$29.1M more FCF
AVNW
$22.5M
$-6.6M
MED
Faster 2-yr revenue CAGR
AVNW
AVNW
Annualised
AVNW
0.3%
-34.4%
MED

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
AVNW
AVNW
MED
MED
Revenue
$111.5M
$75.1M
Net Profit
$5.7M
Gross Margin
32.4%
69.4%
Operating Margin
6.5%
-10.4%
Net Margin
5.1%
Revenue YoY
-5.7%
-36.9%
Net Profit YoY
27.2%
EPS (diluted)
$0.44
$-1.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AVNW
AVNW
MED
MED
Q4 25
$111.5M
$75.1M
Q3 25
$107.3M
$89.4M
Q2 25
$115.3M
$105.6M
Q1 25
$112.6M
$115.7M
Q4 24
$118.2M
$119.0M
Q3 24
$88.4M
$140.2M
Q2 24
$116.7M
$168.6M
Q1 24
$110.8M
$174.7M
Net Profit
AVNW
AVNW
MED
MED
Q4 25
$5.7M
Q3 25
$162.0K
$-2.3M
Q2 25
$5.2M
$2.5M
Q1 25
$3.5M
$-772.0K
Q4 24
$4.5M
Q3 24
$-11.9M
$1.1M
Q2 24
$1.5M
$-8.2M
Q1 24
$3.9M
$8.3M
Gross Margin
AVNW
AVNW
MED
MED
Q4 25
32.4%
69.4%
Q3 25
33.2%
69.5%
Q2 25
34.2%
72.6%
Q1 25
34.9%
72.8%
Q4 24
34.6%
74.1%
Q3 24
22.4%
75.4%
Q2 24
35.3%
73.2%
Q1 24
32.5%
72.8%
Operating Margin
AVNW
AVNW
MED
MED
Q4 25
6.5%
-10.4%
Q3 25
4.8%
-4.6%
Q2 25
7.7%
-1.0%
Q1 25
8.3%
-1.1%
Q4 24
6.7%
0.6%
Q3 24
-17.6%
1.5%
Q2 24
4.7%
-4.7%
Q1 24
5.1%
4.5%
Net Margin
AVNW
AVNW
MED
MED
Q4 25
5.1%
Q3 25
0.2%
-2.5%
Q2 25
4.5%
2.3%
Q1 25
3.1%
-0.7%
Q4 24
3.8%
Q3 24
-13.4%
0.8%
Q2 24
1.3%
-4.8%
Q1 24
3.5%
4.8%
EPS (diluted)
AVNW
AVNW
MED
MED
Q4 25
$0.44
$-1.64
Q3 25
$0.01
$-0.21
Q2 25
$0.42
$0.22
Q1 25
$0.27
$-0.07
Q4 24
$0.35
$0.08
Q3 24
$-0.94
$0.10
Q2 24
$0.11
$-0.75
Q1 24
$0.30
$0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AVNW
AVNW
MED
MED
Cash + ST InvestmentsLiquidity on hand
$86.5M
$167.3M
Total DebtLower is stronger
$105.4M
Stockholders' EquityBook value
$271.6M
$198.9M
Total Assets
$659.4M
$248.0M
Debt / EquityLower = less leverage
0.39×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AVNW
AVNW
MED
MED
Q4 25
$86.5M
$167.3M
Q3 25
$64.8M
$173.5M
Q2 25
$59.7M
$162.7M
Q1 25
$49.4M
$164.6M
Q4 24
$52.6M
$162.3M
Q3 24
$51.0M
$170.0M
Q2 24
$64.6M
$163.5M
Q1 24
$59.2M
$156.4M
Total Debt
AVNW
AVNW
MED
MED
Q4 25
$105.4M
Q3 25
$106.5M
Q2 25
$87.6M
Q1 25
$73.9M
Q4 24
$74.9M
Q3 24
$83.4M
Q2 24
$48.4M
Q1 24
$48.9M
Stockholders' Equity
AVNW
AVNW
MED
MED
Q4 25
$271.6M
$198.9M
Q3 25
$263.6M
$214.7M
Q2 25
$263.2M
$216.0M
Q1 25
$256.1M
$211.0M
Q4 24
$249.6M
$210.1M
Q3 24
$247.1M
$207.3M
Q2 24
$255.9M
$205.3M
Q1 24
$256.0M
$211.0M
Total Assets
AVNW
AVNW
MED
MED
Q4 25
$659.4M
$248.0M
Q3 25
$643.3M
$268.2M
Q2 25
$633.3M
$269.3M
Q1 25
$628.3M
$280.0M
Q4 24
$594.1M
$284.2M
Q3 24
$590.9M
$291.2M
Q2 24
$535.2M
$293.5M
Q1 24
$490.3M
$302.8M
Debt / Equity
AVNW
AVNW
MED
MED
Q4 25
0.39×
Q3 25
0.40×
Q2 25
0.33×
Q1 25
0.29×
Q4 24
0.30×
Q3 24
0.34×
Q2 24
0.19×
Q1 24
0.19×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AVNW
AVNW
MED
MED
Operating Cash FlowLast quarter
$23.9M
$-5.3M
Free Cash FlowOCF − Capex
$22.5M
$-6.6M
FCF MarginFCF / Revenue
20.2%
-8.8%
Capex IntensityCapex / Revenue
1.3%
1.8%
Cash ConversionOCF / Net Profit
4.18×
TTM Free Cash FlowTrailing 4 quarters
$16.1M
$1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AVNW
AVNW
MED
MED
Q4 25
$23.9M
$-5.3M
Q3 25
$-11.7M
$12.1M
Q2 25
$10.5M
$-3.4M
Q1 25
$1.6M
$3.4M
Q4 24
$20.8M
$-4.9M
Q3 24
$-27.2M
$9.1M
Q2 24
$8.3M
$13.1M
Q1 24
$15.3M
$7.3M
Free Cash Flow
AVNW
AVNW
MED
MED
Q4 25
$22.5M
$-6.6M
Q3 25
$-13.5M
$10.8M
Q2 25
$8.2M
$-4.8M
Q1 25
$-1.2M
$1.9M
Q4 24
$18.3M
$-7.2M
Q3 24
$-32.6M
$7.7M
Q2 24
$7.5M
$11.1M
Q1 24
$14.8M
$5.4M
FCF Margin
AVNW
AVNW
MED
MED
Q4 25
20.2%
-8.8%
Q3 25
-12.6%
12.0%
Q2 25
7.1%
-4.5%
Q1 25
-1.0%
1.6%
Q4 24
15.5%
-6.1%
Q3 24
-36.8%
5.5%
Q2 24
6.4%
6.6%
Q1 24
13.4%
3.1%
Capex Intensity
AVNW
AVNW
MED
MED
Q4 25
1.3%
1.8%
Q3 25
1.6%
1.5%
Q2 25
2.0%
1.3%
Q1 25
2.5%
1.3%
Q4 24
2.1%
1.9%
Q3 24
6.1%
1.0%
Q2 24
0.7%
1.1%
Q1 24
0.4%
1.1%
Cash Conversion
AVNW
AVNW
MED
MED
Q4 25
4.18×
Q3 25
-72.48×
Q2 25
2.02×
-1.36×
Q1 25
0.46×
Q4 24
4.62×
Q3 24
8.04×
Q2 24
5.37×
Q1 24
3.96×
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AVNW
AVNW

Products$81.2M73%
Services$30.3M27%

MED
MED

Segment breakdown not available.

Related Comparisons